Fluorescence Imaging Device Receives Clearance

The MolecuLight i:X (MolecuLight Inc, Toronto, Ontario, Canada) received de novo clearance from the Food and Drug Administration, permitting expansion of the product into the United States market. The product is indicated as a handheld imaging device that allows clinicians to digitally record images of a wound and the fluorescence emitted when exposed to an excitation light. It is compact, portable, and optimized for use at the point-of-care.

Visit www.moleculight.com for more information.